Correlation of drug absorption with molecular surface properties.

The correlation between dynamic surface properties of drug molecules and drug absorption in two common in vitro models of the intestinal wall (Caco-2 monolayers and rat intestinal segments) has been investigated. A homologous series of beta-adrenoreceptor antagonists were used as model compounds. Dynamic molecular surface properties, considering all low-energy conformations, of the compounds were calculated. The flexibility of the molecules was studied by molecular mechanics calculations (MM2) and the van der Waals' (vdW), and water accessible surface areas were calculated and averaged according to a Boltzmann distribution. Excellent correlations were obtained between the dynamic polar vdW surface areas and cell permeabilities in Caco-2 cells and rat ileum (r2 = 0.99 and 0.92, respectively). These correlations were stronger than those between calculated octanol/buffer partition coefficients (log Doct,7.4) and permeability (r2 = 0.80 and 0.73, respectively). Moreover, the calculated log Doct,7.4 values failed to rank the permeability coefficients through Caco-2 monolayers and rat ileum in the correct order. The results indicate that dynamic polar surface area is a promising alternative model for the prediction of oral drug absorption.

[1]  B. Lee,et al.  The interpretation of protein structures: estimation of static accessibility. , 1971, Journal of molecular biology.

[2]  Samuel H. Yalkowsky,et al.  Solubility of nonelectrolytes in polar solvents. V. Estimation of the solubility of aliphatic monofunctional compounds in water using a molecular surface area approach , 1975 .

[3]  C Silipo,et al.  Calculation of hydrophobic constant (log P) from pi and f constants. , 1975, Journal of medicinal chemistry.

[4]  W. Higuchi,et al.  Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes , 1980 .

[5]  Y. Martin,et al.  A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry. , 1981, Journal of medicinal chemistry.

[6]  R. Pownall,et al.  The absorption of β‐adrenoceptor antagonists in rat in‐situ small intestine; the effect of lipophilicity , 1985, The Journal of pharmacy and pharmacology.

[7]  H. Scheraga,et al.  Accessible surface areas as a measure of the thermodynamic parameters of hydration of peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  W J Dunn,et al.  The role of solvent-accessible surface area in determining partition coefficients. , 1987, Journal of medicinal chemistry.

[9]  6th International Symposium of Nephrology at Montecatini on Kidney, Proteins and Drugs , 1988 .

[10]  R Griffiths,et al.  Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. , 1988, Journal of medicinal chemistry.

[11]  Kenny B. Lipkowitz,et al.  Dynamic molecular surface areas , 1989 .

[12]  G. Chang,et al.  Macromodel—an integrated software system for modeling organic and bioorganic molecules using molecular mechanics , 1990 .

[13]  Raimund Mannhold,et al.  Drug lipophilicity in QSAR practice. I: A comparison of experimental with calculative approaches , 1990 .

[14]  P. Artursson,et al.  Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells. , 1990, Journal of pharmaceutical sciences.

[15]  P. Artursson Cell cultures as models for drug absorption across the intestinal mucosa. , 1991, Critical reviews in therapeutic drug carrier systems.

[16]  P. Artursson,et al.  A method for the determination of cellular permeability coefficients and aqueous boundary layer thickness in monolayers of intestinal epithelial caco 2 cells grown in permeable filter chambers , 1991 .

[17]  R. Frizzell,et al.  Intestinal absorption and secretion , 1991 .

[18]  P. Artursson,et al.  Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.

[19]  G. Painter,et al.  Role of desolvation energy in the nonfacilitated membrane permeability of dideoxyribose analogs of thymidine. , 1992, Molecular pharmacology.

[20]  A. Ungell,et al.  Effects of enzymatic inhibition and increased paracellular shunting on transport of vasopressin analogues in the rat. , 1992, Journal of pharmaceutical sciences.

[21]  M. Kansy,et al.  Hydrogen-Bonding Capacity and Brain Penetration , 1992, Chimia (Basel).

[22]  M C Manning,et al.  Delta-sleep-inducing peptide: solution conformational studies of a membrane-permeable peptide. , 1994, Biochemistry.

[23]  Bernard Testa,et al.  Lipophilicity and hydrogen-bonding capacity of H1-antihistaminic agents in relation to their central sedative side-effects , 1994 .

[24]  D. Barlow,et al.  The design of peptide analogues for improved absorption , 1994 .